Blu – Pagina 198 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Maggio 2, 2019 Alice Lione

Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity – A Randomized Clinical Trial

Baker CW, Glassman AR, Beaulieu WT, et al.
JAMA. Pub. online 29 April 2019

Leggi

Maggio 2, 2019 Alice Lione

Patients with good vision and diabetic macular edema involving the center of the macula – To Treat or Not to Treat?

Chew EY
JAMA. Pub. online 29 April 2019

Leggi

Aprile 19, 2019 Alice Lione

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Heerspink HJL, Parving HH, Andress DL, et al.
The Lancet. Pub. online 14 April 2019

Leggi

Aprile 19, 2019 Alice Lione

Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics

Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, et al.
JACC. 2019;73(15) :1931-44

Leggi

Aprile 19, 2019 Alice Lione

SGLT2 Inhibition. Changing what fuels the heart

Lehrke M
JACC. 2019;73(15):1945-7

Leggi

Aprile 19, 2019 Alice Lione

A turning point for chronic kidney disease in diabetes

Tuttle KR
The Lancet. Pub. online 14 April 2019

Leggi

Aprile 19, 2019 Alice Lione

SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease

Tuttle KR
The Lancet Diabetes & Endocrinology. Pub. online 13 April 2019

Leggi

Aprile 19, 2019 Alice Lione

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

Pollock C, Stefánsson B, Reyner D, et al.
The Lancet Diabetes & Endocrinology. Pub. online 13 April 2019

Leggi

Aprile 19, 2019 Alice Lione

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

Perkovic V, Jardine MJ, Neal B, et al. for the CREDENCE Trial Investigators
NEJM. Pub. Online 14 April 2019

Leggi

Aprile 15, 2019 Alice Lione

Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation

Blair JC, McKay A, Ridyard C, et al.
BMJ. 2019;365:l1226

Leggi